Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 2,525.00
-70.00 (-2.70%)
Jun 11, 2026, 3:10 PM KST
Access Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -83,168 | -82,118 | -347.58 | -3,173 | 346,670 | 189,690 |
Depreciation & Amortization | 14,496 | 17,160 | 20,078 | 15,960 | 10,826 | 6,064 |
Loss (Gain) From Sale of Assets | 366.32 | 124.61 | 3.4 | 0.88 | 40.6 | -19.12 |
Asset Writedown & Restructuring Costs | 46,423 | 46,423 | 1,496 | -1,943 | 1.08 | - |
Loss (Gain) From Sale of Investments | 5,577 | 6,074 | 5,072 | -1,067 | -12.55 | - |
Loss (Gain) on Equity Investments | 268.2 | - | - | - | - | - |
Stock-Based Compensation | - | - | - | 977.5 | 1,195 | 454.38 |
Provision & Write-off of Bad Debts | -481.76 | 584.58 | 56.73 | -66,354 | -2,407 | 76,625 |
Other Operating Activities | -24,655 | -28,326 | -36,531 | -13,810 | 62.93 | -7,174 |
Change in Accounts Receivable | 3,061 | 4,335 | 11,464 | 140,948 | -31,612 | -102,046 |
Change in Inventory | -1,133 | 4,608 | 31,400 | 74,137 | -66,079 | -28,282 |
Change in Accounts Payable | 1,722 | -628.43 | -2,190 | 1,355 | -8,051 | 5,000 |
Change in Unearned Revenue | 51.99 | -44.79 | - | -544.92 | - | 120.56 |
Change in Other Net Operating Assets | -33,131 | 2,625 | -10,598 | -250,368 | 118,564 | 23,043 |
Operating Cash Flow | -70,603 | -29,183 | 19,904 | -103,882 | 369,198 | 163,477 |
Operating Cash Flow Growth | - | - | - | - | 125.84% | 358.68% |
Capital Expenditures | -984.22 | -1,791 | -2,051 | -18,615 | -18,753 | -34,079 |
Sale of Property, Plant & Equipment | 277.05 | 199.41 | 4.21 | 98.36 | 1,489 | 34.3 |
Divestitures | - | - | - | - | 998.63 | - |
Sale (Purchase) of Intangibles | -512.4 | -0.33 | -2.61 | -56.77 | -23.32 | -14.49 |
Sale (Purchase) of Real Estate | - | - | - | - | -121.7 | -15.5 |
Investment in Securities | -9,631 | 4,807 | 573.88 | -41,490 | -27,963 | - |
Other Investing Activities | 15,600 | 18,575 | 19,334 | 14,460 | 5,929 | -901.29 |
Investing Cash Flow | 4,759 | 21,800 | 17,469 | -46,491 | -37,754 | -34,930 |
Long-Term Debt Issued | - | - | - | - | 14,714 | 30,299 |
Total Debt Issued | - | - | - | - | 14,714 | 30,299 |
Short-Term Debt Repaid | - | - | - | - | -15,936 | -9,761 |
Long-Term Debt Repaid | - | -4,868 | -7,546 | -6,451 | -38,144 | -2,572 |
Total Debt Repaid | -3,982 | -4,868 | -7,546 | -6,451 | -54,079 | -12,333 |
Net Debt Issued (Repaid) | -3,982 | -4,868 | -7,546 | -6,451 | -39,366 | 17,966 |
Issuance of Common Stock | - | - | - | 406.53 | 9.31 | 15.01 |
Repurchase of Common Stock | - | - | - | -2,366 | -28,058 | - |
Dividends Paid | - | - | - | -29,341 | - | - |
Other Financing Activities | 10.09 | 10.09 | -9.43 | -16,237 | -0 | 24.46 |
Financing Cash Flow | -3,972 | -4,858 | -7,556 | -53,989 | -67,414 | 18,005 |
Foreign Exchange Rate Adjustments | -1,017 | 1,510 | -4,062 | 518.05 | -3,650 | -1,090 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | -0 | - | 0 |
Net Cash Flow | -70,832 | -10,731 | 25,755 | -203,844 | 260,379 | 145,462 |
Free Cash Flow | -71,587 | -30,974 | 17,853 | -122,498 | 350,444 | 129,398 |
Free Cash Flow Growth | - | - | - | - | 170.83% | 412.35% |
Free Cash Flow Margin | -479.19% | -99.10% | 15.88% | -35.14% | 33.90% | 25.62% |
Free Cash Flow Per Share | -2034.83 | -879.62 | 719.10 | -3625.74 | 9259.21 | 3468.64 |
Cash Interest Paid | 641.36 | 660.12 | 1,036 | 1,098 | 950.78 | 249.74 |
Cash Income Tax Paid | - | -1,635 | -5,572 | 14,796 | 124,095 | 89,040 |
Levered Free Cash Flow | -34,495 | -24,792 | 23,758 | 1,508 | 294,780 | 111,287 |
Unlevered Free Cash Flow | -33,223 | -23,342 | 25,927 | 3,827 | 298,675 | 113,380 |
Change in Working Capital | -29,429 | 10,895 | 30,076 | -34,474 | 12,822 | -102,164 |